Genotyping Characteristics of Human Fecal

Humans Escherichia coli / genetics Escherichia coli Infections / epidemiology Multilocus Sequence Typing Genotype Beijing Drug Resistance, Multiple, Bacterial / genetics Anti-Bacterial Agents / pharmacology Diarrhea Microbial Sensitivity Tests
Antibiotic resistance genes E. coli Multidrug resistance Random forest Whole-genome sequencing

Journal

Biomedical and environmental sciences : BES
ISSN: 2214-0190
Titre abrégé: Biomed Environ Sci
Pays: China
ID NLM: 8909524

Informations de publication

Date de publication:
20 May 2023
Historique:
received: 26 02 2023
accepted: 07 04 2023
medline: 1 6 2023
pubmed: 31 5 2023
entrez: 30 5 2023
Statut: ppublish

Résumé

To explore the genotyping characteristics of human fecal Over a period of 3 years, 94 This study revealed that 68.09% of the isolates had MDR, prevalent and distributed in different clades, with a relatively high rate and low pathogenicity. There was no difference in MDR between the diarrheal (49/70) and healthy groups (15/24). We developed a random forest (RF) prediction model of

Identifiants

DOI: 10.3967/bes2023.050 PMID: 37253667
pubmed: 37253667
doi: 10.3967/bes2023.050
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

406-417

Informations de copyright

Copyright © 2023 The Editorial Board of Biomedical and Environmental Sciences. Published by China CDC. All rights reserved.

Auteurs

Wei Wei Zhang (WW)

National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China;Miyun District Center for Disease Control and Prevention, Beijing 101520, China.

Xiao Lin Zhu (XL)

Berger Bioengineering Co., Ltd, Shanghai 201401, China.

Le Le Deng (LL)

National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.

Ya Jun Han (YJ)

National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.

Zhuo Wei Li (ZW)

National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.

Jin Long Wang (JL)

Xicheng District Commission of Health of Beijing Municipality, Beijing 100044, China.

Yong Liang Chen (YL)

Miyun District Center for Disease Control and Prevention, Beijing 101520, China.

Ao Lin Wang (AL)

Miyun District Center for Disease Control and Prevention, Beijing 101520, China.

Er Li Tian (EL)

Miyun District Center for Disease Control and Prevention, Beijing 101520, China.

Bin Cheng (B)

Miyun District Hospital, Beijing 101520, China.

Lin Hua Xu (LH)

Hebei North University, Zhangjiakou 075000, Heibei, China.

Yi Cong Chen (YC)

Hebei North University, Zhangjiakou 075000, Heibei, China.

Li Li Tian (LL)

Miyun District Center for Disease Control and Prevention, Beijing 101520, China.

Guang Xue He (GX)

National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Genotyping Characteristics of Human Fecal
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Enterobacteriaceae › Escherichia › Escherichia coli › Genotyping Characteristics of Human Fecal
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Infections à Enterobacteriaceae › Infections à Escherichia coli › Genotyping Characteristics of Human Fecal
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Analyse de séquence d'ADN › Typage par séquençage multilocus › Genotyping Characteristics of Human Fecal
questionsmedicales.fr › Phénomènes génétiques › Génotype › Genotyping Characteristics of Human Fecal
questionsmedicales.fr › Régions géographiques › Villes › Pékin › Genotyping Characteristics of Human Fecal
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Multirésistance aux médicaments › Multirésistance bactérienne aux médicaments › Genotyping Characteristics of Human Fecal
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Genotyping Characteristics of Human Fecal
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Signes et symptômes digestifs › Diarrhée › Genotyping Characteristics of Human Fecal
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Genotyping Characteristics of Human Fecal